From Invetech
The IVD industry faces many challenges from growing public health issues in the developed world and epidemics in developing nations through to growing regulatory demands for swift and flexible responses.
This article, written by Warren Hancock, Invetech Director, examines the various market forces that have shaped the IVD industry and its supporting instrumentation over the last 15 years, and how IVD manufacturers have responded to meet market needs.
Products & Services
Topics of Interest
IVD manufacturers have not only improved lab instruments but also adapted them for emerging technologies. Warren Hancock and Andrew Evans During the past decade, the IVD instrument market has...
In June, the U.S. Supreme Court dismissed the patent infringement case of Laboratory Corp. of America v. Metabolite Laboratories. The Court declined to rule on whether the granting of a patent can...
Examining the effects of the IVD Directive The European Union’s Directive 98/79/EC on In Vitro Diagnostic Medical Devices (IVD Directive) was first published on December 7, 1998. The directive...
Filters, membranes, and bioseparation equipment and supplies The Human Genome Project started a revolution that has spawned a cluster of new molecular biological technologies. Created out of research...
Using specialty labs to develop IVDs Specialty labs offer IVD manufacturers expertise in standardization and generation of clinical utility data. Developing an IVD assay with broad utility as a...
